4.5 Review

Potential of Lipid-Based Nanocarriers against Two Major Barriers to Drug Delivery-Skin and Blood-Brain Barrier

期刊

MEMBRANES
卷 13, 期 3, 页码 -

出版社

MDPI
DOI: 10.3390/membranes13030343

关键词

biological barriers; drug delivery; lipid-based nanocarriers; BBB; skin; solid lipid nanoparticles (SLN); nanostructured lipid carriers (NLC)

向作者/读者索取更多资源

In recent years, the pharmaceutical and biomedical fields have achieved remarkable advancements in medicine, diagnostics, and drug delivery, with nanotechnology-based tools playing a major role. The use of nanotechnology in drug delivery has led to the development of innovative strategies and materials to improve patient compliance. Lipid-based nanocarriers offer a potential solution to overcome biological barriers, such as the skin and blood-brain barrier, by facilitating drug penetration and enhancing their effectiveness.
Over the past few years, pharmaceutical and biomedical areas have made the most astounding accomplishments in the field of medicine, diagnostics and drug delivery. Nanotechnology-based tools have played a major role in this. The implementation of this multifaceted nanotechnology concept encourages the advancement of innovative strategies and materials for improving patient compliance. The plausible usage of nanotechnology in drug delivery prompts an extension of lipid-based nanocarriers with a special reference to barriers such as the skin and blood-brain barrier (BBB) that have been discussed in the given manuscript. The limited permeability of these two intriguing biological barriers restricts the penetration of active moieties through the skin and brain, resulting in futile outcomes in several related ailments. Lipid-based nanocarriers provide a possible solution to this problem by facilitating the penetration of drugs across these obstacles, which leads to improvements in their effectiveness. A special emphasis in this review is placed on the composition, mechanism of penetration and recent applications of these carriers. It also includes recent research and the latest findings in the form of patents and clinical trials in this field. The presented data demonstrate the capability of these carriers as potential drug delivery systems across the skin (referred to as topical, dermal and transdermal delivery) as well as to the brain, which can be exploited further for the development of safe and efficacious products.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据